The general considerations about strategies to identify and mitigate risks for early clinical trials of investigational new drugs
DAI Xue-dong
WANG Qing-li
SUN Tao
Machine-generated Keywords：
Publication Date：2020-09-30
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：6( 2060-2065 )